Skip to main content
Premium Trial:

Request an Annual Quote

Grifols Takes 20 Percent Stake in Singulex

NEW YORK (GenomeWeb) – Spanish healthcare products firm Grifols said today that it has invested $50 million for a 20 percent stake in diagnostics and laboratory testing services firm Singulex. 

According to a filing with the US Securities and Exchange Commission, the investment has a fully diluted pre-money valuation of $200 million and entitles Grifols to appoint a director to Singulex's board.

The deal also provides Grifols with an exclusive worldwide license to Singulex's single-molecule counting technology — which allows for the detection of single molecules such as proteins and metabolites in complex biological samples — for use in blood donor and plasma screening. Singulex licensed the research-use rights to the technology to EMD Millipore last year.

The Singulex deal marks the latest step in Grifols ongoing effort to bolster its diagnostics division. Earlier this year, the company exercised an option to acquire 32.9 percent of Progenika, boosting its stake in the molecular diagnostics company to 89.1 percent. And in late 2013, Grifols acquired Novartis' transfusion diagnostics business for $1.68 billion.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.